Fractyl Health, Inc. Common Stock (GUTS) Stock Price

GUTSStock

$1.55−89.83%52W

Market Cap$20.56M

P/E—

PEG Ratio—

Div yield—

Beta2.67

GUTS Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-84.50%

Price vs S&P 500 (4W)-76.08%

VGM Score7.88

Book Value / Share (Quarterly)$0.13

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.52

Price vs S&P 500 (YTD)-106.06%

Gross Margin (TTM)46.24%

Net Profit Margin (TTM)-73864.52%

EPS (TTM)$-2.07

10-Day Avg Trading Volume1.68M

EPS Excl Extra (TTM)$-2.07

EPS (Annual)$-1.86

ROI (Annual)-352.00%

Gross Margin (Annual)46.24%

Cash / Share (Quarterly)$0.30

ROA (Last FY)-116.11%

Revenue Growth TTM (YoY)-96.91%

EBITD / Share (TTM)$-1.26

ROE (5Y Avg)-424.16%

Operating Margin (TTM)-100570.97%

Cash Flow / Share (Annual)$-0.59

P/B Ratio2.58x

P/B Ratio (Quarterly)3.40x

Net Income / Employee (Annual)$-1,409,500

EV / Revenue (TTM)413.85x

Net Interest Coverage (TTM)-43.27x

ROA (TTM)-148.09%

EPS Incl Extra (Annual)$-1.86

Current Ratio (Annual)4.78x

Quick Ratio (Quarterly)3.00x

3-Month Avg Trading Volume0.32M

52-Week Price Return-89.83%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)593.36x

Asset Turnover (Annual)0.00x

52-Week High$29.34

EPS Excl Extra (Annual)$-1.86

CapEx CAGR (5Y)208.29%

26-Week Price Return-74.59%

Quick Ratio (Annual)4.45x

13-Week Price Return-84.05%

Total Debt / Equity (Annual)3.23x

Current Ratio (Quarterly)3.15x

Enterprise Value$38.49M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-73864.52%

Cash / Share (Annual)$0.53

3-Month Return Std Dev147.21%

Net Income / Employee (TTM)$-1,409,500

ROE (Last FY)-1490.32%

Net Interest Coverage (Annual)-33.44x

EPS Basic Excl Extra (Annual)$-1.86

Receivables Turnover (TTM)8.45x

Total Debt / Equity (Quarterly)1.41x

EPS Incl Extra (TTM)$-2.07

ROI (TTM)-177.99%

P/S Ratio (TTM)593.36x

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-105.36%

Year-to-Date Return-94.13%

5-Day Price Return-64.85%

EPS Normalized (Annual)$-1.86

ROA (5Y Avg)-78.96%

Net Profit Margin (Annual)-73864.52%

Month-to-Date Return-76.26%

EBITD / Share (Annual)$-1.26

Operating Margin (Annual)-100570.97%

LT Debt / Equity (Annual)3.23x

ROI (5Y Avg)-140.00%

LT Debt / Equity (Quarterly)1.41x

EPS Basic Excl Extra (TTM)$-2.07

P/B Ratio (Annual)31.88x

Inventory Turnover (TTM)0.00x

Pretax Margin (TTM)-73864.52%

Book Value / Share (Annual)$0.06

Price vs S&P 500 (13W)-86.74%

Beta2.67x

Revenue / Share (TTM)$0.00

ROE (TTM)-852.14%

52-Week Low$1.53

vGradeF

gGradeF

mGradeF

vgmGradeF

GUTS Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 10, 2026	-$1.64	-$1.41	+13.88%(+$0.23)
Q1 2026	May 12, 2026	-$1.92	-$1.53	+20.25%(+$0.39)
Q4 2025	Mar 24, 2026	-$2.16	-$0.84	+61.11%(+$1.32)
Q3 2025	Nov 12, 2025	-$3.79	-$8.52	-124.68%(-$4.73)
Q2 2025	Aug 12, 2025	-$0.36	-$0.57	-58.33%(-$0.21)

GUTS Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.18

4.15

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
GUTSFractyl Health, Inc. Common Stock	F	F	F	593.4x	—	46.2%	-100571.0%	$1.55
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Fractyl Health, Inc. Common Stock

Fractyl Health is a metabolic therapeutics company developing treatments for type 2 diabetes and obesity. The company targets organ-level root causes to deliver durable, disease-modifying therapies rather than chronic symptom management.

GUTS Next Earnings Report

Report dateNov 11, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$1.50

Revenue estimate$0

Also reporting on Nov 11, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

GUTS Insider Transactions

BuySep 14, 2026
BRADLEY WILLIAM C
Director
Shares: 64,516Value: $39,903

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

BCHTBirchtech Corp.Measuring & Controlling Devices
MLSSMilestone Scientific, Inc. Common StockOrthopedic & Prosthetic Devices
ITOCiTonic Holdings Ltd Class A Ordinary SharesElectromedical Equipment
DAIOData I/O CorpInstruments for Measuring
LFWDLifeward Ltd. Ordinary SharesOrthopedic & Prosthetic Devices
CLIRClearSign Technologies Corporation Common Stock (DE)Industrial Instruments
BNGOBionano Genomics, Inc. Common StockLab Analytical Instruments
IRIXIridex CorpElectromedical Equipment

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Buy

Consensus rating

52-Week Range

Low$1.53

High$29.34